Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Pia Huusko"'
Autor:
Maija Wolf, Henrik Edgren, Aslaug Muggerud, Sami Kilpinen, Pia Huusko, Therese Sørlie, Spyro Mousses, Olli Kallioniemi
Publikováno v:
Cellular Oncology, Vol 27, Iss 3, Pp 169-173 (2005)
Gene mutations play a critical role in cancer development and progression, and their identification offers possibilities for accurate diagnostics and therapeutic targeting. Finding genes undergoing mutations is challenging and slow, even in the post-
Externí odkaz:
https://doaj.org/article/0f22c64c81d7405987e6ba768500a099
Autor:
Maija Wolf, Spyro Mousses, Sampsa Hautaniemi, Ritva Karhu, Pia Huusko, Minna Allinen, Abdel Elkahloun, Outi Monni, Yidong Chen, Anne Kallioniemi, Olli-P Kallioniemi
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 6, Iss 3, Pp 240-247 (2004)
Identification of target genes for genetic rearrangements in prostate cancer and the impact of copy number changes on gene expression are currently not well understood. Here, we applied high-resolution comparative genomic hybridization (CGH) on cDNA
Externí odkaz:
https://doaj.org/article/c3db72a623b54bb9a18aa4eeada48002
Autor:
Curtis A. Pettaway, Isaac Powell, Terry Mason, Pia Huusko, Rick A. Kittles, Agnes Boffoe-Bonnie, Gerald Hoke, John D. Carpten, Jeffrey M. Trent, Sally P. Weinrich, Francis S. Collins, James T. Bennett, Christiane M. Robbins, Chiledum Ahaghotu, Tracy Moses, Georgia M. Dunston, Paulette Furbert-Harris, Spyro Mousses, Srinivasan Vijayakumar, Joan E. Bailey-Wilson
Publikováno v:
Journal of Medical Genetics. 43:507-511
Background: The EphB2 gene was recently implicated as a prostate cancer (PC) tumour suppressor gene, with somatic inactivating mutations occurring in ∼10% of sporadic tumours. We evaluated the contribution of EphB2 to inherited PC susceptibility in
Autor:
Sami Kilpinen, Pia Huusko, Spyro Mousses, Therese Sørlie, Olli Kallioniemi, Aslaug Aamodt Muggerud, Henrik Edgren, Maija Wolf
Publikováno v:
Cellular Oncology, Vol 27, Iss 3, Pp 169-173 (2005)
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology
Wolf, M, Edgren, H, Muggerud, A, Kilpinen, S, Huusko, P, Sørlie, T, Mousses, S & Kallioniemi, O 2005, ' NMD microarray analysis for rapid genome-wide screen of mutated genes in cancer ', Cellular Oncology, vol. 27, no. 3, pp. 169-173 . < https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617499/# >
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology
Wolf, M, Edgren, H, Muggerud, A, Kilpinen, S, Huusko, P, Sørlie, T, Mousses, S & Kallioniemi, O 2005, ' NMD microarray analysis for rapid genome-wide screen of mutated genes in cancer ', Cellular Oncology, vol. 27, no. 3, pp. 169-173 . < https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617499/# >
Gene mutations play a critical role in cancer development and progression, and their identification offers possibilities for accurate diagnostics and therapeutic targeting. Finding genes undergoing mutations is challenging and slow, even in the post-
Autor:
Heli Nevanlinna, Rosa B. Barkardottir, Juha Kere, Olli Kallioniemi, Tommi Kainu, Laura Sarantaus, Valgardur Egilsson, Paula Vehmanen, Kirsi Syrjäkoski, Adalgeir Arason, Seppo Pyrhönen, Kaija Holli, Ralf Krahe, Pia Huusko, Pär-Ola Bendahl
Publikováno v:
European Journal of Human Genetics. 9:773-779
The 999del5 mutation is the single, strong BRCA2 founder mutation in Iceland and the most common BRCA1/2 founder mutation in Finland. To evaluate the origin and time since spreading of the 999del5 mutation in Iceland and in Finland, we constructed ha
Autor:
Marika Kujala, Kati Pääkkönen, Heli Nevanlinna, Robert Winqvist, Pia Huusko, Jaana Lahti-Domenici, Katrin Rapakko, Minna Allinen
Publikováno v:
Cancer Genetics and Cytogenetics. 129:120-123
In the Finnish population, identified mutations in BRCA1 and BRCA2 account for a less than expected proportion of hereditary breast and ovarian cancer. All previous studies performed in our country have concentrated on finding germ-line mutations in
Autor:
Pia Vahteristo, Minna Allinen, Kirsi Syrjäkoski, Robert Winqvist, Tommi Kainu, K Vähäkangas, Pia Huusko, Heli Nevanlinna, Olli Kallioniemi, Hannaleena Eerola, Katrin Rapakko
Publikováno v:
British Journal of Cancer
We have screened for germline TP53 mutations in Finnish BRCA1 and BRCA2 mutation-negative families. This study represents the largest survey of the entire protein-encoding portion of TP53, and indicates that mutations are only found at conserved doma
Autor:
Antti Kauppila, Robert Winqvist, Risto Bloigu, Veli-Matti Kosma, Virpi Launonen, Seppo Saarikoski, Maarit Anttila, Arto Mannermaa, Pia Huusko, Frej Stenbäck, Ulla Puistola
Publikováno v:
Cancer Genetics and Cytogenetics. 122:49-54
Tumor specimens from 78 epithelial ovarian cancer patients were examined for loss of heterozygosity (LOH) at 11 microsatellite markers at chromosomes 3p14.2, 6q27, 8p12, 11p15.5, 11q23.1-q24, 16q24.3, and 17p13.1, to evaluate the involvement, possibl
Autor:
Valgerdur Sigurdardottir, P Rio, Rosette Lidereau, M. W. Beckmann, Javier Benitez, Laura J. van't Veer, Siegfried Scherneck, Natasa Sever, K. Laake, Robert Winqvist, Ivan Bièche, Pia Huusko, Eva Skovlund, Susanne Seitz, Edith Olah, Jorunn E. Eyfjord, Annegien Broeks, Sarah J. Plummer, Yves-Jean Bignon, Marie Hélène Champème, Dieter Niederacher, Nigel K. Spurr, Virpi Launonen, Borut Peterlin, Anne-Marie Cleton-Jansen, Jenny Varley, Gavin R M White, Daniel Birnbaum, Anne Lise Børresen-Dale, Ana Osorio, Åke Borg, Marianna Sztan, Sigfridur Gudlaugsdottir, Graham Casey
Publikováno v:
Genes, Chromosomes and Cancer. 25:212-221
Among the chromosomal regions commonly undergoing deletions in breast tumors is 11q23.1. The genes that are targets for loss of heterozygosity (LOH) in this region is not yet established. One of the candidate genes located in this region is ATM, resp
Autor:
Kati Pääkkönen, Virpi Launonen, Jaakko Leisti, Robert Winqvist, Pia Huusko, Katariina Castrén, Ylermi Soini, K Vähäkangas
Publikováno v:
Cancer Genetics and Cytogenetics. 112:9-14
Mutations in BRCA1 and BRCA2 account for a large portion of the inherited predisposition to breast and ovarian cancer. It was recently discovered that mutations in these two genes are less common in the Finnish population than expected. Because the g